Use of machine-learning algorithms to aid in the early detection of leptospirosis in dogs. (July 2022)

• Record Type: Journal Article
• Authors: Reagan, Krystle L.; Deng, Shaofeng; Sheng, Junda; Sebastian, Jamie; Wang, Zhe; Huebner, Sara N.; Wenke, Louise A.; Michalak, Sarah R.; Strohmer, Thomas; Sykes, Jane E.
• Is Part Of: Journal of veterinary diagnostic investigation. Volume 34:Number 4(2022)
• Page Start: 612
• Page End: 621
• Publication Date: 2022-07
• Subjects: artificial intelligence -- dogs -- infection -- kidney -- Leptospira; Veterinary medicine -- Diagnosis -- Periodicals; 636.0896075
• DOI: 10.1177/10406387221096781
• Languages: English
• ISSNs: 1040-6387

Abstract

Leptospirosis is a life-threatening, zoonotic disease with various clinical presentations, including renal injury, hepatic injury, pancreatitis, and pulmonary hemorrhage. With prompt recognition of the disease and treatment, 90% of infected dogs have a positive outcome. Therefore, rapid, early diagnosis of leptospirosis is crucial. Testing for Leptospira -specific serum antibodies using the microscopic agglutination test (MAT) lacks sensitivity early in the disease process, and diagnosis can take >2 wk because of the need to demonstrate a rise in titer. We applied machine-learning algorithms to clinical variables from the first day of hospitalization to create machine-learning prediction models (MLMs). The models incorporated patient signalment, clinicopathologic data (CBC, serum chemistry profile, and urinalysis = blood work [BW] model), with or without a MAT titer obtained at patient intake (=BW + MAT model). The models were trained with data from 91 dogs with confirmed leptospirosis and 322 dogs without leptospirosis. Once trained, the models were tested with a cohort of dogs not included in the model training (9 leptospirosis-positive and 44 leptospirosis-negative dogs), and performance was assessed. Both models predicted leptospirosis in the test set with 100% sensitivity (95% CI: 70.1–100%). Specificity was 90.9% (95% CI: 78.8–96.4%) and 93.2% (95% CI: 81.8–97.7%) for the BW and BW + MAT models, respectively. Our MLMs outperformed traditional acute serologic screening and can provide accurate early screening for the probable diagnosis of leptospirosis in dogs.